Filing Details
- Accession Number:
- 0001193125-20-025348
- Form Type:
- 13G Filing
- Publication Date:
- 2020-02-05 16:04:08
- Filed By:
- Cui Jingrong Jean
- Company:
- Turning Point Therapeutics Inc. (NASDAQ:TPTX)
- Filing Date:
- 2020-02-05
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Beneficially Owned Number of Shares | Beneficially Owned Number of Aggregate Shares | Percent of Class |
|---|---|---|---|
| Jingrong Jean Cui | 2,607,852 | 0 | 2,607,852 |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Turning Point Therapeutics, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
90041T 108
(CUSIP Number)
December 31, 2019
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
| * | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
13G
| CUSIP No. 90041T 108 | Page 2 of 5 Pages |
| 1. | Names of Reporting Persons
Jingrong Jean Cui | |||||
| 2. | Check the Appropriate Box if a Member of a Group (see instructions) (a) ☐ (b) ☐
| |||||
| 3. | SEC USE ONLY
| |||||
| 4. | Citizenship or Place of Organization
United States | |||||
| Number of Shares Beneficially Owned by Each Reporting Person With: | 5. | Sole Voting Power
2,607,852(1) | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
2,607,852(1) | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
2,607,852(1) | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions) ☐
| |||||
| 11. | Percent of Class Represented by Amount in Row 9
7.2%(2) | |||||
| 12. | Type of Reporting Person (see instructions)
IN | |||||
(1) Includes (a) 936,219 shares held by the Reporting Persons spouse and (b) 370,335 shares issuable to the Reporting Person upon exercise of options to purchase common stock within 60 days of December 31, 2019.
(2) Based on 36,285,454 shares of Common Stock outstanding on December 31, 2019. Assumes the exercise of the Reporting Persons options exercisable as of within 60 days of December 31, 2019.
13G
| CUSIP No. 90041T 108 | Page 3 of 5 Pages |
| Item 1. |
| (a) | Name of Issuer |
| Turning Point Therapeutics, Inc., a Delaware corporation |
| (b) | Address of Issuers Principal Executive Offices |
| 10628 Science Center Drive, Suite 200 |
| San Diego, CA 92121 |
| Item 2. |
| (a) | Name of Person Filing |
| Jingrong Jean Cui |
| (b) | Address of Principal Business Office or, if none, Residence |
| 10628 Science Center Drive, Suite 200 |
| San Diego, CA 92121 |
| (c) | Citizenship |
| United States |
| (d) | Title of Class of Securities |
| Common Stock |
| (e) | CUSIP Number |
| 90041T 108 |
| Item 3. | Not applicable |
| Item 4. | Ownership |
| (a) | Amount Beneficially Owned: |
2,607,852 shares, including (a) 936,219 shares held by the Reporting Persons spouse and (b) 370,335 shares issuable to the Reporting Person upon exercise of options to purchase common stock within 60 days of December 31, 2019.
13G
| CUSIP No. 90041T 108 | Page 4 of 5 Pages |
| (b) | Percent of Class: 7.2% |
| (c) | Number of shares as to which the person has: |
| (i) | Sole power to vote or to direct the vote: 2,607,852 |
| (ii) | Shared power to vote or to direct the vote: 0 |
| (iii) | Sole power to dispose or to direct the disposition of: 2,607,852 |
| (iv) | Shared power to dispose or to direct the disposition of: 0 |
| Item 5. | Ownership of Five Percent or Less of a Class |
Not applicable
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
Not applicable
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. |
Not applicable
| Item 8. | Identification and Classification of Members of the Group |
Not applicable
| Item 9. | Notice of Dissolution of a Group |
Not applicable
| Item 10. | Certification. |
Not applicable
13G
| CUSIP No. 90041T 108 | Page 5 of 5 Pages |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| 2/3/2020 |
| Date |
| /s/ Jingrong Jean Cui |
| Signature |
| Jingrong Jean Cui |
| Name/Title |